News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Nuvilex Release: Therapeutic Antibody Producing Cells Encapsulated Using Cell-in-a-Box® Encapsulation Technology Proven Effective for Targeted Treatment of Various Diseases


4/3/2012 9:57:04 AM

SILVER SPRING, Md.--(BUSINESS WIRE)--Nuvilex, Inc. (OTCQB:NVLX), an emerging biotechnology provider of cell and gene therapy solutions through acquisition of SG Austria assets, realizes the important role for Cell-in-a-Box® technology and aims to bring to light its use in the production of therapeutic antibodies for clinically important diseases.

Read at BioSpace.com

comments powered by Disqus
Nuvilex
 
 

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES